What is the next step in evaluating and managing a patient with persistent nausea after a normal esophagogastroduodenoscopy (EGD) and normal wireless pH‑impedance (Bravo) study?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 14, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Next Step: Perform Gastric Emptying Study

After normal EGD and Bravo pH-impedance studies in a patient with persistent nausea, the next step is to obtain a gastric emptying study to evaluate for gastroparesis or functional dyspepsia. 1

Diagnostic Algorithm

1. Gastric Emptying Study (First Priority)

  • Order a 4-hour solid-phase gastric emptying scintigraphy using standardized methodology (low-fat egg white meal)
  • This distinguishes gastroparesis (delayed emptying) from functional dyspepsia (normal emptying) 1
  • Verify proper test methodology—improper technique is a common pitfall that leads to misdiagnosis 1

2. Interpretation Based on Results

If Gastric Emptying is Delayed (Gastroparesis):

  • Classify severity: mild, moderate, or severe based on degree of delay 1
  • Identify the predominant symptom (nausea in this case) and treat accordingly 1
  • For nausea/vomiting specifically:
    • Consider antiemetics (5-HT3 antagonists, NK-1 receptor antagonists)
    • Trial prokinetic agents if available
    • Consider neuromodulators (TCAs, SNRIs) for refractory cases 1
    • Gastric electrical stimulation reserved for refractory/intractable cases failing standard therapy 1

If Gastric Emptying is Normal (Functional Dyspepsia):

  • This becomes a diagnosis of functional dyspepsia with nausea as the predominant symptom 2
  • Treatment options include:
    • Neuromodulators (tricyclic antidepressants like amitriptyline 10-50mg) as first-line for symptom modulation 2
    • Prokinetic agents (if available in your region)
    • Consider mirtazapine or SNRIs for dual benefit on nausea and visceral hypersensitivity 2
    • Early dietitian involvement to avoid overly restrictive eating patterns 2

Important Clinical Considerations

Why This Sequence Matters

Your patient has already excluded:

  • Structural/mucosal disease (normal EGD)
  • Acid reflux as primary cause (normal Bravo pH-impedance)

The gastric emptying study is the critical next test because nausea with normal upper endoscopy and pH testing most commonly represents either gastroparesis or functional dyspepsia—conditions that overlap significantly in symptoms but require different management approaches 1.

Common Pitfall to Avoid

Do not assume normal pH testing completely excludes reflux-related nausea. While your patient had normal Bravo testing, one study showed that extended wireless pH monitoring can identify GERD in 33-34% of patients with negative 24-hour catheter studies 3. However, since you've already performed Bravo (which is extended monitoring), this is less likely the issue here.

Additional Considerations

  • Screen for eating disorders/ARFID (avoidant restrictive food intake disorder), especially if there's significant food restriction or weight loss 2
  • Assess for psychological comorbidities (anxiety, depression) that commonly coexist and may require concurrent treatment 2
  • Review medication list for agents that delay gastric emptying (opioids, anticholinergics, GLP-1 agonists)

Treatment Approach Based on Predominant Symptom

Since nausea is the primary complaint, target nausea specifically rather than treating all potential gastroparesis/dyspepsia symptoms 1:

  • Antiemetics (ondansetron, promethazine)
  • NK-1 receptor antagonists (aprepitant) show promise 2
  • Neuromodulators work centrally on nausea pathways and visceral hypersensitivity 1, 2

Avoid opioids for any associated abdominal pain, as they worsen gastric emptying and nausea 1.

References

Related Questions

What do my esophagogastroduodenoscopy (EGD) results indicate?
What is the ICD-10 code for esophageal atresia?
Can guanfacine (Intuniv) or sertraline (Zoloft) cause gastroesophageal reflux disease (GERD) and nausea in a 13-year-old?
How should I manage gastroesophageal reflux disease (GERD) and nausea in a 17‑year‑old male with ulcerative colitis who is taking prednisone and mesalamine and has a gastroenterology appointment on Thursday?
In an elderly patient who experiences nausea first thing in the morning, could this be due to gastro‑oesophageal reflux disease (GERD)?
What are the prescribing guidelines for Baxfendy (baxdrostat) in adult patients with uncontrolled hypertension on background antihypertensive therapy, including starting dose, dose titration, contraindications, required laboratory monitoring, renal function considerations, and precautions regarding potassium‑sparing agents?
What is the cause of heat sensation and excessive sweating in a patient with Parkinson disease on levodopa therapy, and how should it be evaluated and managed?
Can mildly elevated mean platelet volume and mild eosinophilia cause facial melasma in a 32‑year‑old unmarried female?
What is the likely diagnosis and recommended management for a 32‑year‑old female with bilateral cheek hyperpigmentation?
How can I gradually reduce my levodopa (levodopa‑carbidopa) dose to address heat sensation and excessive sweating while preserving motor function?
In an older adult with frontotemporal dementia, how does alprazolam compare to clonazepam in terms of efficacy, safety, dosing schedule, and risk of sedation, falls, and cognitive decline?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.